Senior insider sale
Chief Medical Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$7.15M
102.96K shares
What this filing means
SLOAN SHELDON plans to sell 102.96K shares of SPYRE THERAPEUTICS, INC. valued at approximately $7.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/3/2026ACC: 0001950047-26-005572
Officer· Chief Medical Officer
Since Oct 2024
102.96K
Shares to sell
$7.15M
Approx. market value
16.67K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/3/2026
16.67KTotal acquired16.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2026 | Exercise of Stock Options Cash | 16.67K | — |
| Total | 16.67K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
78.33K
Market value
$5.60M
5/1/2026
—Completed
Units to sell
7.96K
Market value
$397.9K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.67K
Market value
$1.15M
6/3/2026
Total
Units
102.96K
Value
$7.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 78.33K | $5.60M | — | Completed |
4/1/2026 | 7.96K | $397.9K | — | Completed |
| Planned — Approximate Date | ||||
6/3/2026 | 16.67K | $1.15M | NASDAQ | Planned |
| Total | 102.96K | $7.15M | ||